Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparing Angiomax to Heparin With Protamine Reversal in Patients OPCAB
This study is ongoing, but not recruiting participants.
Study NCT00073593   Information provided by The Medicines Company
First Received: November 26, 2003   Last Updated: November 9, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cardiac Surgery
Coronary Artery Bypass Surgery
Additional drug interventions recognized in this trial
Anticoagulants
Bivalirudin
Heparin
More general drug interventions related to this trial
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
The Medicines Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services